- Tempus Ex uses AI to automate content and personalise streams
- Enlarged firm to create sports-specific technologies
Sports technology startup Tempus Ex Machina has acquired injury analytics firm Biocore and is rebranding as Infinite Athlete, promising to create an “operating system for sport” that serves fans, athletes and the wider industry.
Biocore specialises in biomechanical engineering, with its data science teams developing analytics platforms that allow teams, federations and athletes to understand and prevent injuries.
Infinite Athlete will combine these innovations with Tempus Ex Machina’s machine learning-powered FusionFeed technology, which analyses every play from every game to automatically generate clips and personalised highlights packages for partners.
FusionFeed powers Tempus Ex’s flagship Match View X (MVX) product, which can also be used to deliver personalised broadcasts, complete with customisable graphical overlays, real-time statistics, play-by-play match events, player tracking, and instant highlights.
The hope is that a combined platform will be able to offer sports-specific innovations in the field of media consumption, performance, fan experience, coaching and team operations, helping to drive the sector’s wider digital transformation.
“With the success of Tempus Ex technology products and Biocore’s work on groundbreaking technology around improving athlete performance and injury severity reduction, there is a demonstrated need for our products within the ecosystem of sports and live events,” said Charlie Ebersol, Infinite Athlete chief executive.
“The world of sports has operated with incremental innovation for years – people continue to improve the same things, but ultimately we still aren’t where we need to be. Together with Biocore leadership, we created Infinite Athlete to bring key technologies together to improve all aspects of sports – the game, the athlete, and the fan experience.”
“We have been utilising Tempus Ex’s proprietary FusionFeed technology for quite some time and it has revolutionised our technology and processes,” added Dr Jeff Crandall, Biocore chief executive. “This merger, and the creation of Infinite Athlete is the most ideal situation for the next phase of Biocore as it will allow us to reach more athletes, across more sports, and provide the best possible solutions to our clients.”
Tempus Ex, which was named as one of SportsPro’s sports technology ideas to invest in class of 2023, works with the likes of the Premier League’s Chelsea, the National Football League’s (NFL) San Francisco 49ers and the Pac-12 college sports conference.
In 2021, Tempus Ex closed a Series B funding round led by private equity firm Silver Lake and Endeavor, the parent company of the Ultimate Fighting Championship (UFC), and appointed Arizona Cardinals legend Larry Fitzgerald to its board of directors.